Kriptic Pharmaceuticals Limited
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
Jun 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 14, 2027.
Recent changes
- 1 of the patents on this record was granted since Aug 16, 2026
- 1 term has ended since Aug 16, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,663,645 | Use of native peptides and their optimized derivatives for vaccination In force · From the USPTO record | In force | From the USPTO record | |
| US 8,900,600 | Identification, optimization and use of cryptic HLA-A24 epitopes for immunotherapy In force · From the USPTO record | In force | From the USPTO record | |
| US 8,465,747 | Identification, optimization and use of cryptic HLA-B7 epitopes for immunotherapy In force · From the USPTO record | In force | From the USPTO record | |
| US 10,024,868 | Identification, optimization and use of shared HLA-B*0702 epitopes for immunotherapy In force · From the USPTO record | In force | From the USPTO record | |
| US 12,048,737 | Use of a Vaccine Targeting a Cryptic Tert Epitope, for Treating Cancer in a HLA-A*0201-Positive Patient Having a Non-Immunogenic Tumor Expressing Tert In force · Medium confidence | In force | Medium confidence | |
| US 12,728,158 | Combination of Markers for Predicting the Response to Vx-001 In force · Medium confidence | In force | Medium confidence | |
| US 7,973,128 | Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof In force Term ended Sep 30, 2026 · From the USPTO record | In force | Term ended Sep 30, 2026 | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending